Shinichiro Yamamoto
Overview
Explore the profile of Shinichiro Yamamoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
1534
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Anillin actin-binding protein expression correlates with poor prognosis for prostate cancer patients
Yamamoto S, Obinata D, Takayama K, Funakoshi D, Fujiwara K, Hara M, et al.
Asian J Urol
. 2024 Nov;
11(4):569-574.
PMID: 39533998
Objective: Octamer transcription factor 1 (OCT1), a transcription factor that interacts with androgen receptor, is involved in prostate cancer (PCa) progression. The OCT1 target gene, Anillin actin-binding protein (), is...
2.
Sakaguchi R, Takahashi N, Yoshida T, Ogawa N, Ueda Y, Hamano S, et al.
J Biol Chem
. 2024 Aug;
300(9):107705.
PMID: 39178948
The cell signaling molecules nitric oxide (NO) and Ca regulate diverse biological processes through their closely coordinated activities directed by signaling protein complexes. However, it remains unclear how dynamically the...
3.
Yamamoto S, Kiyatake N, Kaneko A, Shimamura M, Yoshida T, Shimizu S
Genes Cells
. 2024 Jan;
29(3):254-269.
PMID: 38247314
Transient receptor potential melastatin 2 (TRPM2) assembles into tetramers to function as an oxidative stress-sensitive Ca channel at the surface membrane. Limited information is currently available on the 10 protein...
4.
Funakoshi D, Obinata D, Fujiwara K, Yamamoto S, Takayama K, Hara M, et al.
Biochem Biophys Res Commun
. 2022 Jul;
623:9-16.
PMID: 35868070
Androgens and androgen receptor (AR) have a central role in prostate cancer progression by regulating its downstream signaling. Although androgen depletion therapy (ADT) is the primary treatment for most prostate...
5.
Ishibashi M, Ishii M, Yamamoto S, Mori Y, Shimizu S
Eur J Pharmacol
. 2020 Nov;
891:173671.
PMID: 33131720
Transient receptor potential melastatin 2 (TRPM2) is an oxidative stress-sensitive Ca-permeable channel. The activation of TRPM2 by HO causes cell death in various types of cells. 5-Fluorouracil (5-FU) is an...
6.
Kakizawa S, Kishimoto Y, Yamamoto S, Onga K, Yasuda K, Miyamoto Y, et al.
Sci Rep
. 2020 Sep;
10(1):14475.
PMID: 32879382
Intracellular Ca levels are changed by influx from extracellular medium and release from intracellular stores. In the central nervous systems, Ca release is involved in various physiological events, such as...
7.
Yamamoto S, Ishii T, Mikami R, Numata T, Shimizu S
Biochem Biophys Res Commun
. 2019 Oct;
520(3):520-525.
PMID: 31610913
Membrane proteins are targeted to the surface transmembrane after folding and assembling in the endoplasmic reticulum (ER). Misfolded- and unassembled-proteins are degraded by proteasomes following ubiquitination, termed ER-associated degradation (ERAD)....
8.
Yamamoto S, Takayama K, Obinata D, Fujiwara K, Ashikari D, Takahashi S, et al.
Cancer Sci
. 2019 Aug;
110(11):3476-3485.
PMID: 31454442
Octamer transcription factor 1 (OCT1) is an androgen receptor (AR)-interacting partner and regulates the expression of target genes in prostate cancer cells. However, the function of OCT1 in castration-resistant prostate...
9.
Takayama K, Suzuki Y, Yamamoto S, Obinata D, Takahashi S, Inoue S
Endocrinology
. 2019 Jan;
160(2):463-472.
PMID: 30649323
The ligand-dependent transcription factor androgen receptor (AR) plays a critical role in prostate cancer progression. We previously reported that Octamer transcription factor 1 (OCT1), an AR collaborative factor, facilitated the...
10.
Toda T, Yamamoto S, Umehara N, Mori Y, Wakamori M, Shimizu S
J Pharmacol Exp Ther
. 2018 Dec;
368(2):246-254.
PMID: 30523061
Activation of transient receptor potential melastatin 2 (TRPM2), an oxidative stress-sensitive Ca-permeable channel, contributes to the aggravation of cerebral ischemia-reperfusion (CIR) injury. Recent studies indicated that treatment with the antidepressant...